Moleculin Biotech, Inc. announced the use of a corporate presentation as part of its communication strategy, which is now available on their website. This presentation is being shared for ...

Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...

The Ph.D. Program in Biomedical Engineering and Biotechnology brings together expertise in related fields from the entire UMass system. The program emphasizes a multidisciplinary, team approach in ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

Live webcasts of the Company’s presentations may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.